The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy

Gynecologic Oncology

Volumn 75, Issue 3, 1999, Pages 328-333

  Tsai, Chien Sheng ^a   Lai, Chyong Huey ^a   Wang, Chun Chieh ^a   Chang, Joseph T ^a   Chang, Ting Chang ^a   Tseng, Chih Jen ^a   Hong, Ji Hong ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Cervical cancer; Postoperative radiotherapy; Prognostic factor; Radical hysterectomy

Indexed keywords

HEMOGLOBIN;

ADULT; ARTICLE; DRUG EFFICACY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TREATMENT FAILURE; UTERINE CERVIX CANCER;

EID: 0032801367     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5527     Document Type: Article

References (28)

1. Delgado G, Bundy B, Zaino R, Sevin B U, Creasman W T, Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study. Gynecol Oncol. 38:1990;352-357.
2. Lai C H, Chang H C, Chang T C, Hsueh S, Tang S G. Prognostic factors and impacts of adjuvant therapy in early-stage cervical carcinoma with pelvic node metastases. Gynecol Oncol. 51:1993;390-396.
3. Atkovar G, Uzel O, Ozsahin M, Koca S, Sahinler I, Okkan S, Uzel R. Postoperative radiotherapy in carcinoma of the cervix: Treatment results and prognostic factors. Radiother Oncol. 35:1995;198-205.
4. Sevin B U, Lu Y, Bloch D A, Nadji M, Koechli O R, Averette H E. Surgically defined prognostic parameters in patients with early cervical carcinoma. A multivariate survival tree analysis. Cancer. 78:1996;1438-1446.
5. Lin H H, Cheng W F, Chan K W, Chang D Y, Chen C K, Huang S C. Risk factors for recurrence in patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Obstet Gynecol. 88:1996;274-279.
6. Schorge J O, Molpus K L, Koelliker D, Nikrui N, Goodman A, Fuller A F Jr. Stage IB and IIA cervical cancer with negative lymph nodes: The role of adjuvant radiotherapy after radical hysterectomy [see comments]. Gynecol Oncol. 66:1997;31-35.
7. Hart K, Han I, Deppe G, Malviya V, Malone J Jr, Christensenr C, Chuba P, Porter A. Postoperative radiation for cervical cancer with pathologic risk factors. Int J Radiat Oncol Biol Phys. 37:1997;833-838.
8. Kinney W K, Alvarez R D, Reid G C, Schray M F, Soong S J, Morley G W, Podratz K C, Shingleton H M. Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with pelvic nodal metastasis: A matched-control study. Gynecol Oncol. 34:1989;258-262.
9. Stock R G, Chen A S, Flickinger J C, Kalnicki S, Seski J. Node-positive cervical cancer: Impact of pelvic irradiation and patterns of failure. Int J Radiat Oncol Biol Phys. 31:1995;31-36.
10. Curtin J P, Hoskins W J, Venkatraman E S, Almadrones L, Podratz K C, Long H, Teneriello M, Averette H A, Sevin B U. Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): A randomized phase III trial [see comments]. Gynecol Oncol. 61:1996;3-10.
11. Tseng C J, Chang C T, Lai C H, Soong Y K, Hong J H, Tang S G, Hsueh S. A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix. Gynecol Oncol. 66:1997;52-58.
12. Cox J D, Stetz J, Pajak T F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 31:1995;1341-1346.
13. Lai C H, Lin T S, Chen H F. Adjuvant chemotherapy after radical hysterectomy for cervical cancer - Preliminary report. Chang Gung Med J. 10:1987;314-321.
14. Lai C H, Hong J H, Hsueh S, Ng K K, Chang T C, Tseng C J, Chou H H, Huang K G. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases. Cancer. 85:1999;1537-1546.
15. Hong J H, Tsai C S, Chang J T, Wang C C, Lai C H, Lee S P, Tseng C J, Chang T C, Tang S G. The prognostic significance of pre- and post-treatment SCC levels in patients with squamous cell carcinoma of the cervix treated by irradiation. Int J Radiat Oncol Biol Phys. 41:1998;823-830.
16. Kamura T, Tsukamoto N, Tsuruchi N, Saito T, Matsuyama T, Akazawa K, Nakano H. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer. 69:1992;181-186.
17. Sevin B U, Nadji M, Lampe B, Lu Y, Hilsenbeck S, Koechli O R, Averette H E. Prognostic factors of early stage cervical cancer treated by radical hysterectomy. Cancer. 76:1995;1978-1986.
18. Delgado G, Bundy B N, Fowler W C Jr, Stehman F B, Sevin B, Creasman W T, Major F, DiSaia P, Zaino R. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: A Gynecologic Oncology Group Study. Gynecol Oncol. 35:1989;314-320.
19. Buckley S L, Tritz D M, Van Le L, Higgins R, Sevin B U, Ueland F R, DePriest P D, Gallion H H, Bailey C L, Kryscio R J, Fowler W, Averette H, van Nagell J R Jr. Lymph node metastases and prognosis in patients with stage IA2 cervical cancer. Gynecol Oncol. 63:1996;4-9.
20. Delgado G. Stage IB squamous cancer of the cervix: The choice of treatment. Obstet Gynecol Surv. 33:1978;174-183.
21. Shingleton H M, Jones W B, Russell A, Fremgen A, Chmiel J S, Ocwieja K, Winchester D P, Clive R. Hysterectomy in invasive cervical cancer: A national patterns of care study of the American College of Surgeons. J Am Coll Surg. 183:1996;393-400.
22. Morrow C P. Panel report: Is pelvic radiation beneficial in the postoperative management of Stage IB squamous cell carcinoma of the cervix with pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy? Gynecol Oncol. 10:1980;105-110.
23. Martimbeau P W, Kjorstad K E, Iversen T. Stage IB carcinoma of the cervix, the Norwegian Radium Hospital. II. Results when pelvic nodes are involved. Obstet Gynecol. 60:1982;215-218.
24. Tinga D J, Timmer P R, Bouma J, Aalders J G. Prognostic significance of single versus multiple lymph node metastases in cervical carcinoma stage IB. Gynecol Oncol. 39:1990;175-180.
25. Inoue T, Morita K. The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB. Cancer. 65:1990;1923-1927.
26. Berman M L, Keys H, Creasman W, DiSaia P, Bundy B, Blessing J. Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study). Gynecol Oncol. 19:1984;8-16.
27. Inoue T, Morita K. Long-term observation of patients treated by postoperative extended-field irradiation for nodal metastases from cervical carcinoma stages IB, IIA, and IIB [see comments]. Gynecol Oncol. 58:1995;4-10.
28. Russell A H, Shingleton H M, Jones W B, Stewart A K, Fremgen A, Winchester D P, Clive R, Chimiel J S. Trends in the use of radiation and chemotherapy in the initial management of patients with carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 40:1998;605-613.